The term "investor partnership agreement" is a myth; your legal relationship is defined by specific documents like SAFEs for early stages and a suite of agreements (SPA, IRA, Voting Agreement) for priced rounds. Mastering these terms is non-negotiable for protecting your equity and control. Investor quality is directly reflected in the documents they use—insist on standard forms like the YC Post-Money SAFE and NVCA model docs.
Key takeaways
- Never say "investor partnership agreement." Use the correct names for legal documents.
- For pre-seed, raise on post-money SAFEs. Avoid convertible notes with maturity dates.
- Model your cap table to understand dilution from SAFEs, the option pool, and the new round.
- In a priced round, insist on 1x non-participating liquidation preference.
- Reject non-standard legal documents; they are a major red flag about investor quality.
- Hire a top-tier startup lawyer. Do not use a generalist.
Stop Saying "Investor Partnership Agreement"
Let's get one thing straight: there is no standard legal document called an "Investor Partnership Agreement."
Using that phrase is the fastest way to signal that you're a first-time founder who hasn't done their homework. While you are building a partnership, the legal mechanics are handled by a specific set of documents. Knowing which ones to use—and how to negotiate them—is critical to protecting your ownership and control.
This guide breaks down the actual agreements that will define your relationship with investors, from your first pre-seed check to your Series A.
Early Stage Funding: Convertible Instruments
In the earliest stages (pre-seed and most seed rounds), the vast majority of startups raise money on convertible instruments. This means you don't set a firm price per share today. Instead, investors give you cash in exchange for the right to get equity in a future priced round. This is dramatically faster and cheaper than pricing a round, saving you tens of thousands in legal fees.
The SAFE (Simple Agreement for Future Equity)
The SAFE, created and popularized by Y Combinator, is the undisputed standard for pre-seed funding in Silicon Valley and beyond. It's a simple, founder-friendly document where an investor purchases the right to future stock in your company.
Post-Money Valuation Cap: This is the most important term. It sets the maximum valuation at which the investor's money converts into equity. If you raise $500k on a SAFE with a $10M post-money cap, your investors are guaranteed to own at least 5% of the company ($500k / $10M) when the SAFE converts. If the next round's valuation is lower than the cap, they get an even better price, and thus more equity. · Discount: This gives the SAFE holder a discount on the price per share set in the next funding round. A typical discount is 15-20%. If a SAFE has both a cap and a discount, the investor gets whichever gives them a lower price per share (i.e., more ownership).
Example: You raise $200k on a post-money SAFE with a $12M cap and a 20% discount. A year later, you raise a Series A at a $20M pre-money valuation.
The discount would let them convert at a $16M valuation (20% off $20M). The cap lets them convert at $12M. They will choose the cap, as it gives them a much better price. The discount is only relevant if the next round valuation is low—for example, a $10M pre-money would make the 20% discount ($8M effective valuation) more attractive than the $12M cap.
Crucially, you should only use the YC "Post-Money SAFE" template. It provides the most clarity on dilution. Some older investors or those outside major tech hubs may use "pre-money" SAFEs. The dilution math on these is less predictable, as your ownership stake depends on how many other SAFEs are converting alongside yours. Politely insist on the post-money version as the market standard.
The Convertible Note: A Relic to Avoid (Usually)
The convertible note is the predecessor to the SAFE. It functions similarly, with a valuation cap and/or discount, but with two major drawbacks that make it less founder-friendly. It is technically debt .
Interest Rate: Because it's a loan, the principal accrues interest (typically 2-6% per year). This accrued interest also converts into equity, further increasing investor ownership. · Maturity Date: This is the real danger. The note has a deadline (usually 18-24 months) by which you must raise a priced round. If you don't, the noteholders can demand their money back plus interest. This "ticking clock" can put your company in a precarious position if fundraising takes longer than expected.
For these reasons, SAFEs have replaced convertible notes as the standard. If an investor insists on a note, ask why. Is it a requirement of their fund structure? Or are they simply using outdated documents? If it's the latter, it's a yellow flag about their experience. In most cases, you should hold firm for a standard post-money SAFE.
Priced Rounds (Series A): The Full Document Suite
Once you have product-market fit and strong traction, you'll raise a "priced round" (e.g., Series A, B, etc.). Here, you and a lead investor negotiate a specific pre-money valuation for your company. This process is more complex, more expensive ($50k-$150k+ in legal fees), and involves a whole suite of documents.
The Term Sheet: Your Deal's Blueprint
The process starts with a term sheet. This is a 2-8 page, non-binding summary of the deal's key terms. Once you sign a term sheet with a lead investor, you enter a "no-shop" period where you are exclusively committed to working with them to close the deal. The core terms—valuation, investment amount, option pool size, and board composition—are all negotiated here.
The Definitive Agreements
After the term sheet is signed, lawyers from both sides begin drafting the binding legal documents. A "clean" Series A from a top-tier VC will use the NVCA (National Venture Capital Association) model documents. Serious deviations from these templates are a red flag.
Stock Purchase Agreement (SPA): This is the master agreement to sell a specific number of "Preferred Stock" shares to investors at a fixed price. It also includes your "representations and warranties"—a long list of statements about the business you attest are true (e.g., you own the IP, you are not being sued). Any known exceptions are listed in a "disclosure schedule." · Investors' Rights Agreement (IRA): This critical document grants investors ongoing rights. The key ones are: · Information Rights: The right for major investors to receive regular financial reports (e.g., quarterly statements, an annual budget). · Pro Rata Rights: The right for a major investor to maintain their ownership percentage by participating in future funding rounds. This is a valuable and standard right for your key investors. The "major investor" threshold is often set at those who invested $250k or more. · Voting Agreement: This spells out two things: who is on the Board of Directors and what "protective provisions" the investors get. Protective provisions are a list of corporate actions that require a special vote from the preferred stockholders (i.e., your new investors). This is a formal loss of founder autonomy. Standard provisions are fine; overreaching ones are not. Standard: Require investor approval to sell the company, change the board size, or issue stock with rights senior to theirs. Overreach: Require investor approval to hire/fire executives, approve the annual budget, or take on any debt. Fight to retain these operational controls. · Right of First Refusal and Co-Sale Agreement (ROFR): This restricts anyone from selling their shares to a third party. The company and/or major investors get the first right to buy those shares (ROFR). If they pass, they have the right to sell a proportional number of their own shares alongside the original seller (Co-Sale or "Tag-Along"). This prevents founders from selling large blocks of stock without investor knowledge or participation. · Amended & Restated Certificate of Incorporation: This is the document filed with the state of Delaware to officially create the new class of Preferred Stock. It defines the stock's specific rights, including the most important economic term you will negotiate: the liquidation preference. You must insist on a 1x non-participating preference. This means in a sale, investors can choose to either get their money back (1x) OR convert to common stock and share in the proceeds alongside founders and employees. This is the market standard. Avoid participating preferred stock at all costs. This allows investors to get their money back AND then take their pro-rata share of the remaining proceeds—a "double dip" that is highly founder-unfriendly and signals a predatory investor.
Common Founder Mistakes & How to Avoid Them
Ignoring Option Pool Dilution: Most Series A term sheets require you to create or increase your employee option pool before the new investment. If the round has a $20M pre-money valuation and requires a 10% option pool, the VCs are valuing your existing company at $18M and giving you $2M worth of dilution for the pool. This is the "option pool shuffle," and it means your effective valuation is lower than the headline number. Model this explicitly so you aren't surprised. · Signing Non-Standard Docs: Investor quality is revealed in their documents. A top-tier, founder-friendly VC will send you clean, standard YC SAFEs or NVCA priced round docs. Less experienced or less scrupulous investors will send bespoke agreements full of gotcha clauses. Never accept this. Tell them you only work with standard docs and have your lawyer review every redline. · Giving Away Operational Control: Scrutinize the protective provisions. Giving investors a veto over selling the company is normal. Giving them a veto over your operating budget is not. Don't cede day-to-day control of your company. · Not Hiring a Real Startup Lawyer: Your cousin who handles real estate transactions cannot help you. Venture financing is a highly specialized field. A great startup lawyer has seen hundreds of deals and knows what's market and what's off-market. They are the most valuable partner you will have in a fundraise.
How to Apply This This Week
Read and Annotate the YC Post-Money SAFE: Go to Y Combinator's website, download the latest "Post-Money SAFE" template. Read every line and write down what you think it means. It’s short and surprisingly readable. This is your baseline. · Build a Pro-Forma Cap Table: Create a spreadsheet that shows your current ownership. Then build a second version that models a hypothetical fundraise. Show how ownership changes after new money comes in and all your existing SAFEs convert. You must understand the math. · Start Your Lawyer Search Now: Don't wait for a term sheet. Get introductions from other founders to 2-3 top-tier startup law firms. Do intro calls and learn their fee structure. You want to have your representation ready to go when a deal heats up. · Define Your Red Lines: Write down the 3-5 terms you are not willing to compromise on. Examples: maintaining two founder board seats, never accepting participating preferred stock, or keeping a veto on the company sale.
Mastering these agreements isn't about becoming a lawyer. It’s about being a competent CEO. This knowledge protects your equity, your control, and your ability to build the enduring company you envision.
Frequently asked questions
- What's the difference between a pre-money and post-money SAFE?
- A post-money SAFE cap provides more certainty about your dilution. A $1M check on a $10M post-money cap means the investor buys 10% of the post-investment company. A pre-money cap's dilution depends on how many other SAFEs also convert, making it harder to predict.
- What is a typical valuation cap for a pre-seed round?
- It varies wildly, but as of late 2023/early 2024, typical pre-seed caps for US software startups range from $8M to $15M. Hotter deals in AI can command higher caps, while companies in less-hyped sectors might be lower.
- What are "protective provisions" in a Series A?
- They are veto rights granted to investors. Standard provisions protect them from major actions like selling the company without their consent. Overreaching provisions might give them a veto on your annual budget or executive hires—fight to keep those operational controls.
- Can I negotiate the terms of a SAFE?
- Yes, always. The valuation cap is the most commonly negotiated term. While some investors present their SAFE as "take-it-or-leave-it," you can and should negotiate the cap based on your leverage, traction, and market comparables.